# Auxilius Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/auxilius-pharma

- Industry: Pharmaceuticals
- Headquarters: New York, US
- Website: www.auxiliuspharma.com
- Total disclosed funding: $1M
- Latest round: Seed (Jun 14, 2023)
- Investors on record: 1

## About

Founded in 2018 and based in New York, US, Auxilius Pharma operates as a pharmaceutical development company that develops drugs for patients, healthcare providers, and payers. In June 2023, Auxilius Pharma raised USD 1 million in seed funding from CofounderZone. As of 2023, the company is led by its CEO, Jed Litwiniuk.

Auxilius Pharma develops and offers value-added medicines for the treatment of coronary artery diseases. The company’s product line includes AUX-001, a medication for treating chronic-stable angina pectoris (CSA) that reduces chest pain and other healthcare side effects in the body. The firm’s pipeline project includes PNI19 and PNI23 (cardiovascular drug candidates).

The company plans to use the funds raised in June 2023 to expand its product development.

## Funding rounds

- Seed, Jun 14, 2023, $1M — CofounderZone

## Investors

- CofounderZone (https://capitalatlas.ai/funds/cofounderzone) — Seed